Mission
ProGenosis is a biotechnology company devoted to the determination of protein interactions. Our proprietary technology platform is dedicated to developing efficient, innovative and convenient Bifunctional Hybrid Proteins (BHPs), which can be used for protein domain studies.
ProGenosis provides customized services in R&D to Life Science companies with a primary focus on receptor-ligand interaction.
The company is a spin-off of the Center for Protein Engineering at the University of Liège in Belgium, with privileged access to the latest laboratory research and development.